These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34615858)

  • 1. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth.
    Sun Y; Xie J; Cai S; Wang Q; Feng Z; Li Y; Lu JJ; Chen W; Ye Z
    Cell Death Dis; 2021 Oct; 12(10):913. PubMed ID: 34615858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
    Yuan G; Flores NM; Hausmann S; Lofgren SM; Kharchenko V; Angulo-Ibanez M; Sengupta D; Lu X; Czaban I; Azhibek D; Vicent S; Fischle W; Jaremko M; Fang B; Wistuba II; Chua KF; Roth JA; Minna JD; Shao NY; Jaremko Ł; Mazur PK; Gozani O
    Nature; 2021 Feb; 590(7846):504-508. PubMed ID: 33536620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression.
    Jeong GY; Park MK; Choi HJ; An HW; Park YU; Choi HJ; Park J; Kim HY; Son T; Lee H; Min KW; Oh YH; Lee JY; Kong G
    Cancer Res; 2021 Jan; 81(1):77-90. PubMed ID: 32967925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer.
    Zhu XR; Peng SQ; Wang L; Chen XY; Feng CX; Liu YY; Chen MB
    Cell Death Dis; 2021 Oct; 12(10):918. PubMed ID: 34620839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
    Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
    Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
    Peng SQ; Zhu XR; Zhao MZ; Zhang YF; Wang AR; Chen MB; Ye ZY
    Cell Death Dis; 2023 Feb; 14(2):157. PubMed ID: 36828810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer.
    Zhao LH; Li Q; Huang ZJ; Sun MX; Lu JJ; Zhang XH; Li G; Wu F
    Cell Death Dis; 2021 Oct; 12(11):974. PubMed ID: 34671018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis.
    Liu Z; Piao L; Zhuang M; Qiu X; Xu X; Zhang D; Liu M; Ren D
    Oncol Rep; 2017 Nov; 38(5):2796-2802. PubMed ID: 28901481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [NSD3 suppresses LPS-triggered TNF-α production via promoting the dimethylation of histone H3K36 in macrophages].
    Liu Z; Cheng Q; Yang L; Sun Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jun; 34(6):481-487. PubMed ID: 30236198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.
    Mahmood SF; Gruel N; Nicolle R; Chapeaublanc E; Delattre O; Radvanyi F; Bernard-Pierrot I
    Am J Pathol; 2013 Nov; 183(5):1634-1644. PubMed ID: 24051013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
    Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
    Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
    Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
    Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma.
    Xiang T; Bai JY; She C; Yu DJ; Zhou XZ; Zhao TL
    Cell Signal; 2018 Jan; 42():106-113. PubMed ID: 29050985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
    Yang Y; Tao X; Li CB; Wang CM
    Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.
    Vincent A; Hong SM; Hu C; Omura N; Young A; Kim H; Yu J; Knight S; Ayars M; Griffith M; Van Seuningen I; Maitra A; Goggins M
    Oncotarget; 2014 May; 5(9):2575-87. PubMed ID: 24810906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
    Morishita M; Mevius D; di Luccio E
    BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.
    Böttcher J; Dilworth D; Reiser U; Neumüller RA; Schleicher M; Petronczki M; Zeeb M; Mischerikow N; Allali-Hassani A; Szewczyk MM; Li F; Kennedy S; Vedadi M; Barsyte-Lovejoy D; Brown PJ; Huber KVM; Rogers CM; Wells CI; Fedorov O; Rumpel K; Zoephel A; Mayer M; Wunberg T; Böse D; Zahn S; Arnhof H; Berger H; Reiser C; Hörmann A; Krammer T; Corcokovic M; Sharps B; Winkler S; Häring D; Cockcroft XL; Fuchs JE; Müllauer B; Weiss-Puxbaum A; Gerstberger T; Boehmelt G; Vakoc CR; Arrowsmith CH; Pearson M; McConnell DB
    Nat Chem Biol; 2019 Aug; 15(8):822-829. PubMed ID: 31285596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer.
    Zhu CL; Huang Q
    Dig Dis Sci; 2020 Feb; 65(2):489-499. PubMed ID: 31441002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.